Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $1.4B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx Inc | 2,387,720 | $157M | 11.2% | $65.02 | +4.2% | COMMON STOCK | 03940C100 |
| CYTK | Cytokinetics Inc | 2,590,531 | $104M | 7.4% | $65.54 | -29.9% | COM NEW | 23282W605 |
| INSM | Insmed Inc | 1,075,000 | $82.01M | 5.9% | $55.45 | +37.9% | COM PAR $.01 | 457669307 |
| NUVL | Nuvalent Inc | 1,075,000 | $76.24M | 5.4% | $86.67 | -9.8% | COM | 670703107 |
| VERA | Vera Therapeutics Inc | 2,500,000 | $60.05M | 4.3% | $37.35 | -14.0% | CL A | 92337R101 |
| KALV | KalVista Pharmaceuticals Inc | 4,751,292 | $54.83M | 3.9% | $12.01 | -15.0% | COM | 483497103 |
| QURE | uniQure NV | 4,792,572 | $50.8M | 3.6% | $9.25 | +51.6% | SHS | N90064101 |
| CRNX | Crinetics Pharmaceuticals Inc | 1,500,000 | $50.31M | 3.6% | $37.35 | 0.0% | COM | 22663K107 |
| XENE | Xenon Pharmaceuticals Inc | 1,300,000 | $43.62M | 3.1% | $39.71 | -4.4% | COM | 98420N105 |
| SRRK | Scholar Rock Holding Corp | 1,300,000 | $41.8M | 3.0% | $38.47 | 0.0% | COM | 80706P103 |
| BCAX | Bicara Therapeutics Inc | 2,768,975 | $36.08M | 2.6% | $15.93 | -16.6% | COM | 055477103 |
| GERN | Geron Corp | 22,005,340 | $34.99M | 2.5% | $3.24 | -24.9% | COM | 374163103 |
| FOLD | Amicus Therapeutics Inc | 4,275,000 | $34.88M | 2.5% | $10.15 | -8.8% | COM | 03152W109 |
| IMTX | Immatics NV | 7,192,700 | $32.44M | 2.3% | $9.29 | -43.9% | SHS | N44445109 |
| GPCR | Structure Therapeutics Inc | 1,788,990 | $30.97M | 2.2% | $36.10 | — | SPONSORED ADS | 86366E106 |
| DNTH | Dianthus Therapeutics Inc | 1,700,069 | $30.84M | 2.2% | $23.01 | -4.2% | COM | 252828108 |
| SVRA | Savara Inc | 11,000,000 | $30.47M | 2.2% | $4.17 | -33.9% | COM | 805111101 |
| TYRA | Tyra Biosciences Inc | 2,879,829 | $26.78M | 1.9% | $14.73 | -12.2% | COM | 90240B106 |
| DHR | Danaher Corporation | 125,000 | $25.63M | 1.8% | $216.97 | 0.0% | COM | 235851102 |
| URGN | UroGen Pharma Ltd | 2,152,957 | $23.81M | 1.7% | $12.19 | -12.5% | COM | M96088105 |
| ASND | Ascendis Pharma A/S | 150,142 | $23.4M | 1.7% | $133.54 | — | SPONSORED ADR | 04351P101 |
| — | Astria Therapeutics Inc | 4,180,000 | $22.32M | 1.6% | $10.75 | — | COM | 04635X102 |
| DAWN | Day One Biopharmaceuticals Inc | 2,598,127 | $20.6M | 1.5% | $12.81 | -15.9% | COM | 23954D109 |
| DYN | Dyne Therapeutics Inc | 1,800,000 | $18.83M | 1.3% | $14.30 | 0.0% | COM | 26818M108 |
| RARE | Ultragenyx Pharmaceutical Inc | 500,000 | $18.11M | 1.3% | $46.29 | -10.1% | COM | 90400D108 |
| LQDA | Liquidia Corp | 1,227,403 | $18.1M | 1.3% | $10.54 | +38.4% | COM NEW | 53635D202 |
| COGT | Cogent Biosciences Inc | 3,000,000 | $17.97M | 1.3% | $7.84 | 0.0% | COM | 19240Q201 |
| ESTA | Establishment Labs Holdings In | 433,193 | $17.68M | 1.3% | $41.64 | -10.5% | COM | G31249108 |
| — | Verona Pharma PLC | 267,627 | $16.99M | 1.2% | $46.44 | — | SPONSORED ADS | 925050106 |
| PRGO | Perrigo Co PLC | 587,649 | $16.48M | 1.2% | $26.15 | -0.8% | SHS | G97822103 |
| GEHC | GE HealthCare Technologies Inc | 204,130 | $16.48M | 1.2% | $85.82 | 0.0% | COMMON STOCK | 36266G107 |
| NYXH | Nyxoah SA | 2,318,954 | $16.19M | 1.2% | $8.73 | +16.5% | SHS | B6S7WD106 |
| GMED | Globus Medical Inc | 200,000 | $14.64M | 1.0% | $78.87 | +4.8% | CL A | 379577208 |
| NRIX | Nurix Therapeutics Inc | 1,125,552 | $13.37M | 1.0% | $16.62 | +0.6% | COM | 67080M103 |
| SRPT | Sarepta Therapeutics Inc | 200,000 | $12.76M | 0.9% | $122.55 | -14.1% | COM | 803607100 |
| BRKR | Bruker Corp | 300,000 | $12.52M | 0.9% | $51.78 | 0.0% | COM | 116794108 |
| — | Cidara Therapeutics Inc | 504,542 | $10.87M | 0.8% | $21.54 | — | COM NEW | 171757206 |
| BDTX | Black Diamond Therapeutics Inc | 5,600,000 | $8.68M | 0.6% | $5.15 | -59.3% | COM | 09203E105 |
| MLTX | MoonLake Immunotherapeutics | 200,000 | $7.814M | 0.6% | $43.09 | 0.0% | CLASS A ORD | 61559X104 |
| SLDB | Solid Biosciences Inc | 1,753,558 | $6.488M | 0.5% | $8.93 | -52.0% | COM NEW | 83422E204 |
| IMVT | Immunovant Inc | 350,000 | $5.981M | 0.4% | $21.88 | -4.4% | COM | 45258J102 |
| ZYME | Zymeworks Inc | 500,000 | $5.955M | 0.4% | $12.09 | +12.8% | COM | 98985Y108 |
| — | Applied Therapeutics Inc | 11,500,000 | $5.622M | 0.4% | $1.17 | — | COM | 03828A101 |
| — | iTeos Therapeutics Inc | 900,000 | $5.373M | 0.4% | $14.84 | — | COM | 46565G104 |
| GLPG | Galapagos NV | 200,000 | $5.024M | 0.4% | $35.13 | — | SPON ADR | 36315X101 |
| VYGR | Voyager Therapeutics Inc | 1,249,418 | $4.223M | 0.3% | $7.06 | — | COM | 92915B106 |
| LXEO | Lexeo Therapeutics Inc | 1,136,249 | $3.943M | 0.3% | $12.73 | -65.2% | COM | 52886X107 |
| KNSA | Kiniksa Pharmaceuticals Intl | 169,864 | $3.773M | 0.3% | $20.58 | 0.0% | ORD SHS CL A | G52694109 |
| CLDX | Celldex Therapeutics Inc | 198,646 | $3.605M | 0.3% | $27.17 | -17.8% | COM NEW | 15117B202 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $2.731M | 0.2% | $15.14 | -62.9% | COM CL A | 68277Q105 |
| VTYX | Ventyx Biosciences Inc | 2,000,000 | $2.3M | 0.2% | $3.51 | -51.1% | COM | 92332V107 |
| ARCT | Arcturus Therapeutics Holdings | 211,790 | $2.243M | 0.2% | $15.87 | 0.0% | COM | 03969T109 |
| — | Passage Bio Inc | 6,100,000 | $2.154M | 0.2% | $1.21 | — | COM | 702712100 |
| FATE | Fate Therapeutics Inc | 2,515,850 | $1.988M | 0.1% | $3.20 | -61.7% | COM | 31189P102 |
| ANRO | Alto Neuroscience Inc | 915,000 | $1.976M | 0.1% | $11.75 | -69.5% | COM SHS | 02157Q109 |
| — | Sutro Biopharma Inc | 2,600,000 | $1.692M | 0.1% | $1.83 | — | COM | 869367102 |
| ENGN | Engene Holdings Inc | 370,000 | $1.658M | 0.1% | $7.77 | -20.0% | COM | 29286M105 |
| ALEC | Alector Inc | 504,540 | $621K | 0.0% | $1.63 | 0.0% | COM | 014442107 |
| ATRA | Atara Biotherapeutics Inc | 94,085 | $559K | 0.0% | $14.38 | -39.3% | COM NEW | 046513206 |
| TRAW | Traws Pharma Inc | 175,000 | $403K | 0.0% | $5.36 | -2.9% | COM NEW | 68232V884 |
| MGNX | MacroGenics Inc | 280,000 | $356K | 0.0% | $14.22 | -81.6% | COM | 556099109 |
| TENX | Tenax Therapeutics Inc | 53,439 | $350K | 0.0% | $3.62 | +77.1% | COM NEW | 88032L605 |
| CNTA | Centessa Pharmaceuticals PLC | 14,888 | $214K | 0.0% | $14.38 | — | SPONSORED ADS | 152309100 |